Dr. Seemal Desai is a Diplomate of the American Board of Dermatology, and a Board Certified Dermatologist. He graduated with honors from Emory University. He received his medical training at Morehouse School of Medicine in Atlanta, Georgia, and received his Doctor of Medicine degree with Magna Cum Laude with honors.
Following medical school, Dr. Desai completed his medical internship in Internal Medicine. He then went on to complete his residency at The University of Alabama at Birmingham and served as Chief Resident for the Department of Dermatology.
Dr. Desai has been active on a local, state, and national level with numerous medical organizations. His major accomplishments have been with the American Academy of Dermatology and the American Medical Association and many others, where he has held numerous elected and appointed positions. He is also actively involved in teaching and mentoring medical students and residents and serves as Clinical Assistant Professor of Dermatology at The University of Texas Southwestern Medical Center. He has been involved in academic medicine for over ten years.
Dr. Desai is the author of numerous publications and has been invited to present at countless national and international Dermatology events. His clinical expertise includes the treatment of vitiligo, and other disorders of pigmentation, psoriasis, acne, skin disease in skin of color, cosmeceuticals, and aesthetics. Dr. Desai is very active in the dermatologic community and is the Immediate Past President of the Skin of Color Society, and Past President of the Texas Dermatological Society. In addition, he is a Past President of the Dallas/Ft. Worth Dermatological Society. He also serves on the Board of Directors of the Women’s Dermatologic Society, the Board of Directors of the Global Vitiligo Foundation, and has been on the Board of Directors of SkinPAC and the Skin of Color Society. Dr. Desai was the youngest ever dermatologist elected to the American Academy of Dermatology Board of Directors where he currently serves, and also serves on the AAD Executive Committee. In 2017, Dr. Desai was appointed to serve on the US Food & Drug Administration, Pharmacy Compounding Advisory Committee (PCAC), and is the only dermatologist on this federal hearing committee. He has just been reappointed to another full 4 year term. He also serves as the Associate Editor of the Journal of Clinical & Aesthetic Dermatology and Pigment International.
Click here for more information on the Valeant Research Award.
Read published peer-reviewed articles written your by Skin of Color Society members
Did You Know
Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.
By 2042, more than 50% of the US population will have skin of color.